SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-256315
Filing Date
2021-08-25
Accepted
2021-08-25 16:18:57
Documents
12
Period of Report
2021-08-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d202715d8k.htm   iXBRL 8-K 25712
  Complete submission text file 0001193125-21-256315.txt   153401

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rna-20210824.xsd EX-101.SCH 2918
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20210824_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20210824_pre.xml EX-101.PRE 11878
5 EXTRACTED XBRL INSTANCE DOCUMENT d202715d8k_htm.xml XML 3483
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 211207090
SIC: 2834 Pharmaceutical Preparations